Creative Planning Danaher Corp Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

A detailed history of Creative Planning transactions in Danaher Corp stock. As of the latest transaction made, Creative Planning holds 126,340 shares of DHR stock, worth $29.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
126,340
Previous 122,591 3.06%
Holding current value
$29.2 Million
Previous $30.6 Million 14.67%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$239.25 - $280.76 $896,948 - $1.05 Million
3,749 Added 3.06%
126,340 $35.1 Million
Q2 2024

Aug 15, 2024
BUY
$235.51 - $267.98 $1.64 Million - $1.87 Million
6,969 Added 6.03%
122,591 $30.6 Million
Q1 2024

May 10, 2024
BUY
$224.58 - $256.19 $3.14 Million - $3.58 Million
13,971 Added 13.74%
115,622 $28.9 Million
Q4 2023

Feb 14, 2024
SELL
$185.1 - $233.13 $1.16 Million - $1.46 Million
-6,244 Reduced 5.79%
101,651 $23.5 Million
Q3 2023

Nov 16, 2023
BUY
$233.08 - $265.59 $3.26 Million - $3.71 Million
13,987 Added 14.89%
107,895 $26.8 Million
Q2 2023

Jul 21, 2023
BUY
$224.99 - $256.14 $302,836 - $344,764
1,346 Added 1.45%
93,908 $22.5 Million
Q1 2023

May 15, 2023
BUY
$239.75 - $277.0 $938,861 - $1.08 Million
3,916 Added 4.42%
92,562 $23.3 Million
Q4 2022

Feb 10, 2023
BUY
$241.42 - $282.29 $5.11 Million - $5.97 Million
21,162 Added 31.36%
88,646 $23.5 Million
Q3 2022

Nov 03, 2022
SELL
$247.06 - $1507.4 $912,886 - $5.57 Million
-3,695 Reduced 5.19%
67,484 $17.4 Million
Q2 2022

Aug 15, 2022
BUY
$237.11 - $299.66 $2.71 Million - $3.42 Million
11,429 Added 19.13%
71,179 $18 Million
Q1 2022

May 16, 2022
SELL
$257.27 - $315.76 $803,454 - $986,118
-3,123 Reduced 4.97%
59,750 $17.5 Million
Q4 2021

Feb 11, 2022
BUY
$292.08 - $329.01 $295,584 - $332,958
1,012 Added 1.64%
62,873 $20.7 Million
Q3 2021

Nov 10, 2021
SELL
$272.21 - $332.43 $2.5 Million - $3.05 Million
-9,178 Reduced 12.92%
61,861 $18.8 Million
Q2 2021

Aug 04, 2021
BUY
$225.08 - $271.69 $5.34 Million - $6.44 Million
23,708 Added 50.09%
71,039 $19.1 Million
Q1 2021

Apr 30, 2021
BUY
$212.38 - $245.9 $1.16 Million - $1.34 Million
5,449 Added 13.01%
47,331 $10.7 Million
Q4 2020

Jan 29, 2021
SELL
$212.5 - $245.46 $153,212 - $176,976
-721 Reduced 1.69%
41,882 $9.3 Million
Q3 2020

Nov 05, 2020
BUY
$177.16 - $215.33 $996,702 - $1.21 Million
5,626 Added 15.21%
42,603 $9.17 Million
Q2 2020

Jul 23, 2020
SELL
$128.7 - $176.83 $76,705 - $105,390
-596 Reduced 1.59%
36,977 $6.54 Million
Q1 2020

May 05, 2020
SELL
$121.39 - $169.05 $144,696 - $201,507
-1,192 Reduced 3.07%
37,573 $5.2 Million
Q4 2019

Jan 30, 2020
BUY
$133.47 - $153.48 $164,968 - $189,701
1,236 Added 3.29%
38,765 $5.95 Million
Q3 2019

Nov 01, 2019
BUY
$135.4 - $146.47 $189,018 - $204,472
1,396 Added 3.86%
37,529 $5.42 Million
Q2 2019

Jul 26, 2019
BUY
$124.88 - $143.73 $528,617 - $608,409
4,233 Added 13.27%
36,133 $5.16 Million
Q1 2019

Apr 24, 2019
BUY
$97.62 - $132.29 $117,632 - $159,409
1,205 Added 3.93%
31,900 $4.21 Million
Q4 2018

Feb 01, 2019
SELL
$94.85 - $109.54 $179,266 - $207,030
-1,890 Reduced 5.8%
30,695 $3.17 Million
Q3 2018

Oct 25, 2018
BUY
$98.13 - $108.9 $130,512 - $144,837
1,330 Added 4.26%
32,585 $3.54 Million
Q2 2018

Jul 20, 2018
BUY
$96.1 - $103.24 $228,718 - $245,711
2,380 Added 8.24%
31,255 $3.08 Million
Q1 2018

Apr 18, 2018
BUY
$92.16 - $103.8 $139,991 - $157,672
1,519 Added 5.55%
28,875 $2.83 Million
Q4 2017

Jan 17, 2018
BUY
$85.26 - $94.62 $103,079 - $114,395
1,209 Added 4.62%
27,356 $2.54 Million
Q3 2017

Oct 17, 2017
BUY
$79.29 - $88.45 $2.07 Million - $2.31 Million
26,147
26,147 $2.24 Million

Others Institutions Holding DHR

# of Institutions
2,511
Shares Held
540M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email